pEGFP-N1/PD-L1 Citations (3)

Originally described in: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. PubMed Journal

---

Articles Citing pEGFP-N1/PD-L1

Articles
ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation. Sun R, Meng Z, Lee H, Offringa R, Niehrs C. Cell Chem Biol. 2023 Jul 20;30(7):739-752.e8. doi: 10.1016/j.chembiol.2023.05.010. Epub 2023 Jun 14. PubMed
Nanoscale engagement of programmed death ligand 1 (PD-L1) in membrane lipid raft domains of cancer cells. Civita S, Ruglioni M, Mariangeli M, Barachini S, Salvadori T, Cristiani S, Carnicelli V, Petrini I, Nepita I, Castello M, Diaspro A, Fogli S, Bianchini P, Storti B, Bizzarri R, Danesi R. FEBS J. 2025 Nov;292(22):5979-5997. doi: 10.1111/febs.70238. Epub 2025 Aug 22. PubMed
Intracellular Transport of PD-L1 by Rab10-Positive Tubular Endosomes Originated from Macropinocytic Cups in RAW264 Macrophage-Like Cells. Kawai K, Ishikawa Y, Egami Y, Araki N. Acta Histochem Cytochem. 2025 Oct 24;58(5):183-186. doi: 10.1267/ahc.25-00045. Epub 2025 Oct 17. PubMed

If you have published an article using this material, please email us at to have your article added to this page.